teplizumab (MGA031)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for teplizumab (MGA031), covering 2012-04-19 to 2012-04-19. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Moderate or More Severe Psoriasis [Phase 1, Phase 2]